@docbinujohn

Academic Hepatologist; Associate Chief of Medicine and Chief of GI/Hepatology @Miami VA; Associate Prof @UMiami, Interest in HCC, PBC, cirrhosis

 Miami, FL
umiamihealth.org/sylvester-comprehensive-cancer-center/research/faculty/binu-v-john
Joined March 2019
  • Tweets697
  • Following353
  • Followers406
37Media
Breaking news:@JAMAInternalMed #COVIDVaccination ->delayed in #cirrhosis but works against severe disease! ☝️One dose -> 64.8% ↓ #COVID19 ✌️Two doses ->78.6%↓ COVID19 #livertwitter #medtwitter #GITwitter @MiamiVAMC @VCUHealth @VCU @UMiamiMedNews jamanetwork.com/journals/jam…

mRNA Vaccines and COVID-19 Infection and Hospitalization Among Patients With Cirrhosis

This cohort study examines the association of receipt of the Pfizer BNT162b2 mRNA or the Moderna mRNA-1273 vaccines in patients with cirrhosis compared with a propensity-matched control group of...

jamanetwork.com
6
20
5
95
Best practices for managing ascites, volume overload & hyponatremia in cirrhosis. Our new CPU in @AGA_Gastro shares 1️⃣3️⃣ evidence-based tips to support clinical decision-making. Read more here: ow.ly/4zLY50XLcfX @orman_md @BrettEFortuneMD @AsraniSumeet #GITwitter
4
74
1
181
16,377
🔥Metylated blood-based HCC biomarker is more sensitive than US for #HCC surveillance. #TLM25 by @docbinujohn @AASLDtweets @DrHuangDQ @Apichatka @wonglaihung
1
4
20
1,306
🚨 New insights on managing hepatitis delta virus (HDV): Our new CPU, published in @AGA_Gastro, highlights screening, diagnosis, and therapies. 📖 Read more: ow.ly/wOuS50X6oYO @TatyanaKushner @Robert_J_Wong #GItwitter
4
12
1,692
Today was a full day with our #AGAleaders! Plenty of conversation to chart a path forward for AGA and the future of GI. 🙌🏼 @docbinujohn @LarryKimMD @DrLorenGR @MccutchenDr @MichelleKimMD @ShaziaMSiddique @JHashashMD @IBDimmunology
6
1
14
2,757
MASLD-HCC can occur in absence of cirrhosis Our study 30,414 patients with MASLD in Hepatology HCC risk ↑ by 18% per 5kPa ↑ in LSM In pts with MASLD without cirrhosis, LSM of ≥10 kPa and diabetes, HCC risk is high enough to warrant screening lnkd.in/e5fHZHZ8
1
9
2
25
2,023
MASLD-HCC can occur in absence of cirrhosis Our study 30,414 patients with MASLD in Hepatology HCC risk ↑ by 18% per 5kPa ↑ in LSM In pts with MASLD without cirrhosis, LSM of ≥10 kPa and diabetes, HCC risk is high enough to warrant screening lnkd.in/e5fHZHZ8
1
9
2
25
2,023
We need to spread the word about MASH Awareness is low, particularly amongst people at risk and frontline providers Hot of the presses in @HepCommJournal journals.lww.com/hepcomm/ful… #easl2025
6
23
1
79
6,785
Grateful for the invitation to speak @cddw_clm on "Remote evaluation of liver transplantation" in beautiful Quebec with some great speakers from @UofT . @CynthiaTsien @NaziaSelzner
9
130
Just found out the study section scheduled to review my grant today was canceled. I spent three months writing it, representing five years of work from my lab. Gutted. @NIH
84
371
26
2,117
169,105
NEW in @LancetGastroHep: led by our @juanpabloarab, "Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective" 🍺 🍷 🍹 Needs integrated multidisciplinary teams. #livertwitter #alcoholism @JasmohanBajaj @saulkarpen authors.elsevier.com/a/1kc07…
2
6
393
🚨 NIH funding changes threaten #GIResearch labs and the future of GI patient care! 🚨 AGA President @ibddocmaria calls for action. Share your story about how these changes impact your work. Let's protect the future of digestive disease treatment! ow.ly/OZiz50UZL3Y
12
2
24
5,776
DOGE @elonmusk approach feels like a surgeon trying to remove a small tumor using a saw instead of a scalpel, without pre-op imaging or taking a patient history, and also removing organs that aren’t diseased but that they just don’t like. And with med students doing the procedure
197
452
31
2,279
113,531
📢 Live from #TLM2024 HCC debrief by Neehar Parikh ➡️ Liver stiffness may help refine HCC screening in MASLD pts ➡️ Are lower AFP levels better than the usual cutoffs for screening cured HCV, ALD, and MASLD patients? @AASLDtweets
1
5
25
1,717
Good morning! If you are at #TLM2024 please join us @ 8 am in Ball room 6A where we present our data using liver stiffness measurement to predict HCC risk and to identify patients with MASLD who may qualify for surveillance! @docamitgs @AnjanaPillaiMD @nicole_rich8 @AASLDtweets
2
1
10
397
Good morning San Diego! It's nice to wake up to this view! Looking forward to an exciting day of learning, collaborating and catching up with friends, colleagues and mentors from all over the world! #TLM24 @AASLDtweets @AASLDFoundation @AASLDPresident #livertwitter
1
10
705
Excited to return to my #IBD roots @IBDCedarsSinai to work alongside a great team. Come visit! @AmerGastroAssn
This Post is from an account that no longer exists. Learn more
26
10
208
10,903
New Clinical Practice Update in @AGA_Gastro from Drs. @AmitPatelDukeMD @Duke_GI_, @LorenLaine2, @PaulMoayyedi and Justin Wu offers 9️⃣ pieces of expert advice to guide the integration of P-CABs in the management of foregut disorders. 🔗 Learn more ow.ly/aPpy50U1tE3
17
2
46
6,755
Huge news 4 MASH (NASH). Semaglutide meets both primary end points for phase 3 trial- resolution of MASH & dec fibrosis! Pleasant surprise as phase 2 study met only one! We should soon have a 2nd drug 4 MASH 🙌#livertwitter @AASLDtweets @AmerGastroAssn ml-eu.globenewswire.com/Reso…
3
132
2 days of intense research brainstorming for grants and studies to improve the care of patients with liver disease #VOCAL #PennYaleMiami @mezzacappa_c @RabieeAnahita @serperm @KaplanDeLiver #TamarTaddei @docbinujohn @ggarciatsao
1
3
28
1,697
Replying to @AmerGastroAssn
@AmerGastroAssn advocate @MimiTanMD speaking on the need for strong NIH, DoD, VA funding for GI research 🔬, prior auth & step therapy reform & the need for Medicare physician payment reform #AGAadvocacy
7
16
1,401
Load more